Trial intelligence / Profile preview

Delayed intraarticular methylprednisolone + bupivacaine after total knee arthroplasty

TCTR20250309004Phase 3Not yet recruiting

Sponsor
N/A
Start
Jul 2025
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of methylprednisolone and bupivacaine in postoperative pain, sponsored by N/A. Planned start Jul 2025; status: not yet recruiting.

02

Drugs

methylprednisolonebupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on TCTR20250309004.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20250309004.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call